We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Ingredion
INGR
$6.25B
| $10.7M | 0.04% |
113,250
+23,482
| +26% | +$2.22M |
|
427
Teck Resources
TECK
$31.7B
| $10.7M | 0.04% |
460,946
-18,500
| -4% | -$417K |
|
428
Willis Towers Watson
WTW
$29.9B
| $10.6M | 0.04% |
60,529
+49,488
| +448% | +$8.21M |
|
429
Norfolk Southern
NSC
$71.9B
| $10.6M | 0.04% |
56,725
-14,612
| -20% | -$2.53M |
|
430
EPR Properties
EPR
$4.5B
| $10.6M | 0.04% |
137,809
+115,400
| +515% | +$8.39M |
|
431
NCR Voyix
VYX
$1.04B
| $10.5M | 0.04% |
629,180
-10,758
| -2% | -$178K |
|
432
iShares Core US Aggregate Bond ETF
AGG
$137B
| $10.5M | 0.04% |
96,320
+15,760
| +20% | +$1.69M |
|
433
Aon
AON
$64.6B
| $10.5M | 0.04% |
61,279
-121,011
| -66% | -$19.6M |
|
434
Assured Guaranty
AGO
$3.14B
| $10.3M | 0.04% |
232,900
-30,400
| -12% | -$1.27M |
|
435
Broadridge
BR
$19.4B
| $10.3M | 0.04% |
99,252
+3,781
| +4% | +$379K |
|
436
Regal Rexnord
RRX
$10.2B
| $10.3M | 0.04% |
125,700
-600
| -0.5% | -$47.3K |
|
437
Workday
WDAY
$46B
| $10.2M | 0.04% |
53,134
-82,654
| -61% | -$15M |
|
|
MPT
438
Medical Properties Trust
MPT
$2.11B
| $10.2M | 0.04% |
551,780
+53,000
| +11% | +$945K |
|
|
FL
439
DELISTED
Foot Locker
FL
| $10.1M | 0.04% |
166,701
-6,500
| -4% | -$379K |
|
|
BPMC
440
DELISTED
Blueprint Medicines
BPMC
| $10.1M | 0.04% |
125,790
+95,386
| +314% | +$7.05M |
|
441
Yext
YEXT
$632M
| $10.1M | 0.04% |
460,147
-1,259
| -0.3% | -$22.8K |
|
442
Kennametal
KMT
$2.24B
| $9.9M | 0.04% |
269,300
-4,700
| -2% | -$172K |
|
443
Groupon
GRPN
$762M
| $9.88M | 0.04% |
139,182
+1,642
| +1% | +$116K |
|
444
Timken Company
TKR
$8.08B
| $9.88M | 0.04% |
226,400
-13,500
| -6% | -$574K |
|
445
Sarepta Therapeutics
SRPT
$2.19B
| $9.82M | 0.04% |
82,361
-4,600
| -5% | -$591K |
|
446
Prudential Financial
PRU
$41.2B
| $9.78M | 0.04% |
106,406
-203,133
| -66% | -$18.7M |
|
447
Snap-on
SNA
$19.4B
| $9.76M | 0.04% |
62,334
-88,707
| -59% | -$14.1M |
|
448
Ubiquiti
UI
$34.1B
| $9.73M | 0.04% |
+65,000
| New | +$8.2M |
|
449
Brown-Forman Class B
BF.B
$12B
| $9.56M | 0.04% |
181,061
+8,762
| +5% | +$425K |
|
450
Brookfield
BN
$82.9B
| $9.5M | 0.04% |
570,631
-388,178
| -40% | -$6.04M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.